Thoracic Cancer

Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results 2:28
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results
Yannis Metaxas
Tackling urgent questions in EGFRm NSCLC 2:44
Tackling urgent questions in EGFRm NSCLC
Nicolas Girard
Toxicity: immunotherapy vs chemotherapy 2:09
Toxicity: immunotherapy vs chemotherapy
Benjamin Besse
Exciting results from the ALEX trial 2:23
Exciting results from the ALEX trial
Silvia Novello
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals